These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16230736)

  • 1. The risk for myocardial infarction with cyclooxygenase-2 inhibitors.
    Pijak MR; Huzicka I; Gazdik F
    Ann Intern Med; 2005 Oct; 143(8):616-7; author reply 617-8. PubMed ID: 16230736
    [No Abstract]   [Full Text] [Related]  

  • 2. The risk for myocardial infarction with cyclooxygenase-2 inhibitors.
    Shinmura K; Bolli R
    Ann Intern Med; 2005 Oct; 143(8):617; author reply 617-8. PubMed ID: 16230737
    [No Abstract]   [Full Text] [Related]  

  • 3. The risk for myocardial infarction with cyclooxygenase-2 inhibitors.
    Kim JA; Choi YS; Yoon D; Cho KH
    Ann Intern Med; 2005 Oct; 143(8):615-6; author reply 617-8. PubMed ID: 16230734
    [No Abstract]   [Full Text] [Related]  

  • 4. Summaries for patients. Risk for heart attacks with different NSAIDs.
    Ann Intern Med; 2005 Apr; 142(7):I45. PubMed ID: 15809454
    [No Abstract]   [Full Text] [Related]  

  • 5. The risk for myocardial infarction with cyclooxygenase-2 inhibitors: a population study of elderly adults.
    Lévesque LE; Brophy JM; Zhang B
    Ann Intern Med; 2005 Apr; 142(7):481-9. PubMed ID: 15809459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cardiovascular ffects of COX-2 selective anti-inflammatory agents].
    Halinen MO
    Duodecim; 2001; 117(24):2570-1. PubMed ID: 12183817
    [No Abstract]   [Full Text] [Related]  

  • 7. Reporting of clinical trials of analgesia.
    Katz N
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):605; author reply 606. PubMed ID: 14762388
    [No Abstract]   [Full Text] [Related]  

  • 8. COX 2 inhibitors may increase risk of heart attack.
    Gottlieb S
    BMJ; 2001 Sep; 323(7311):471. PubMed ID: 11532833
    [No Abstract]   [Full Text] [Related]  

  • 9. Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
    Baigent C; Patrono C
    Arthritis Rheum; 2003 Jan; 48(1):12-20. PubMed ID: 12528099
    [No Abstract]   [Full Text] [Related]  

  • 10. [New study of selective COX-2 inhibitors. Protecting the stomach while risking the heart? (interview by Dr. Beate Schumacher)].
    Zeidler H
    MMW Fortschr Med; 2001 Sep; 143(35-36):14. PubMed ID: 11584521
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy and safety of aspirin in the long-term management of atherothrombosis.
    Patrono C
    Haematologica; 2002 Jan; 87(1):6-8. PubMed ID: 11801459
    [No Abstract]   [Full Text] [Related]  

  • 12. Arthritis. Should you be taking a COX-2 inhibitor?
    Harv Health Lett; 2001 Nov; 27(1):1-3. PubMed ID: 11724695
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA advisers warn: COX 2 inhibitors increase risk of heart attack and stroke.
    Lenzer J
    BMJ; 2005 Feb; 330(7489):440. PubMed ID: 15731142
    [No Abstract]   [Full Text] [Related]  

  • 14. Why do COX-2 inhibitors increase risk of cardiovascular events?
    Frankish H
    Lancet; 2002 Apr; 359(9315):1410. PubMed ID: 11978344
    [No Abstract]   [Full Text] [Related]  

  • 15. Cox-2 inhibitors and cardiovascular risk: we defend our data and suggest caution.
    Mukherjee D; Nissen SE; Topol EJ
    Cleve Clin J Med; 2001 Nov; 68(11):963-4. PubMed ID: 11718438
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular events and COX-2 inhibitors.
    Minic M
    JAMA; 2001 Dec; 286(22):2810; author reply 2811-2. PubMed ID: 11735746
    [No Abstract]   [Full Text] [Related]  

  • 17. Late preconditioning against myocardial stunning. Does aspirin close the "second window" of endogenous cardioprotection?
    Przyklenk K; Heusch G
    J Am Coll Cardiol; 2003 Apr; 41(7):1195-7. PubMed ID: 12679221
    [No Abstract]   [Full Text] [Related]  

  • 18. COX-2 chronology.
    Hawkey CJ
    Gut; 2005 Nov; 54(11):1509-14. PubMed ID: 16227351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MI risk prompts rofecoxib withdrawal.
    Thompson CA
    Am J Health Syst Pharm; 2004 Nov; 61(21):2234-6, 2238. PubMed ID: 15552625
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective cyclo-oxygenase-2 inhibitors and myocardial infarction: how strong is the link?
    Howes LG; Krum H
    Drug Saf; 2002; 25(12):829-35. PubMed ID: 12241124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.